ALK5

Aus PlusPedia
Wechseln zu: Navigation, Suche
Entstehender Artikel
Siehe auch
Freie Übersichtsartikel sind nicht verfügbar
Wichtige Übersichtsartikel
Medline Suchterm/ Synonyme (alk5 OR alk-5 OR activin-like kinase 5) sowie alle Variationen von (TGF beta type I receptor OR transforming growth factor beta type I receptor)
Was ist das Rezeptorkomponente für TGF-beta, hat Serin/Threonin-Kinaseaktivität, aktiviert smad2/smad3;smad7, hierdurch Signaltransduktion, beeinflußt Gene mit der Folge Antiproliferation, Fibrose, Matrixproduktion, Zelldifferenzierung epithelialer Zellen zum mesenchyalen Charakter hin, Immunsuppression. Wichtig für Angiogenese und entwicklungsbiologische Vorgänge sowie Wundheilung.
Struktur [1]
Physiologie Signaltransduktion: [2]

Angiogenese: [3][4][5][6][7]

Fibrose/Myofibroblast/Epithelio-mesenchymale Transdifferenzierung: [8][9][10][11][12]

Entwicklungsbiologie: [13][14][15][16][17][18]

Knockout [19][20]
Transgen
Mutation [21][22]
Polymorphismus
Genexpression
Inhibitoren Z.B. SD208, SM16, SB431542, SB505124: [23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38]
Agonisten TGF-beta, GDF11 [39], GDF9[40]

1 Bibliographie

  1. TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch. EMBO J 28(2):88-98 (2009) PMID 19096363
  2. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling. Physiol Genomics 21(3):396-403 (2005) PMID 15769904
  3. Activin-like kinase 5 (ALK5) mediates abnormal proliferation of vascular smooth muscle cells from patients with familial pulmonary arterial hypertension and is involved in the progression of experimental pulmonary arterial hypertension induced by monocrotaline. Am J Pathol 174(2):380-9 (2009) PMID 19116361
  4. Transforming growth factor-beta1 protects against pulmonary artery endothelial cell apoptosis via ALK5. Am J Physiol Lung Cell Mol Physiol 295(1):L123-33 (2008) PMID 18456797
  5. Nonoverlapping expression patterns of ALK1 and ALK5 reveal distinct roles of each receptor in vascular development. Lab Invest 86(2):116-29 (2006) PMID 16344855
  6. TGFbeta1 induces vasculogenesis and inhibits angiogenic sprouting in an embryonic stem cell differentiation model: respective contribution of ALK1 and ALK5. Stem Cells 24(11):2420-7 (2006) PMID 17071858
  7. TGF-beta inhibits vascular sprouting through TGF-beta type I receptor in the mouse embryonic aorta. Tohoku J Exp Med 218(1):63-71 (2009) PMID 19398875
  8. Matrix contraction by dermal fibroblasts requires transforming growth factor-beta/activin-linked kinase 5, heparan sulfate-containing proteoglycans, and MEK/ERK: insights into pathological scarring in chronic fibrotic disease. Am J Pathol 167(6):1699-711 (2005) PMID 16314481
  9. Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol 152(2):485-93 (1998) PMID 9466575
  10. Contribution of activin receptor-like kinase 5 (transforming growth factor beta receptor type I) signaling to the fibrotic phenotype of scleroderma fibroblasts. Arthritis Rheum 54(4):1309-16 (2006) PMID 16575856
  11. TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 127(6 Pt 2):2021-36 (1994) PMID 7806579
  12. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells. J Cell Sci 112 ( Pt 24)():4557-68 (1999) PMID 10574705
  13. Signaling via the Tgf-beta type I receptor Alk5 in heart development. Dev Biol 322(1):208-18 (2008) PMID 18718461
  14. Endoglin and Alk5 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev Biol 304(1):420-32 (2007) PMID 17250821
  15. Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion. Dev Biol 296(2):298-314 (2006) PMID 16806156
  16. Transforming growth factor-beta induces loss of epithelial character and smooth muscle cell differentiation in epicardial cells. Dev Dyn 235(1):82-93 (2006) PMID 16258965
  17. Transforming growth factor-beta stimulates epithelial-mesenchymal transformation in the proepicardium. Dev Dyn 235(1):50-9 (2006) PMID 16245329
  18. Signaling through Tgf-beta type I receptor Alk5 is required for upper lip fusion. Mech Dev 125(9-10):874-82 (2008) PMID 18586087
  19. Defective ALK5 signaling in the neural crest leads to increased postmigratory neural crest cell apoptosis and severe outflow tract defects. BMC Dev Biol 6():51 (2006) PMID 17078885
  20. Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int J Dev Biol 44(3):253-65 (2000) PMID 10853822
  21. Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype. Cancer Res 68(6):1656-66 (2008) PMID 18339844
  22. Disease-associated mutations in conserved residues of ALK-1 kinase domain. Eur J Hum Genet 11(4):279-87 (2003) PMID 12700602
  23. Progressive transforming growth factor beta1-induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor. Am J Respir Crit Care Med 171(8):889-98 (2005) PMID 15563636
  24. SB-431542, a transforming growth factor beta inhibitor, impairs Trypanosoma cruzi infection in cardiomyocytes and parasite cycle completion. Antimicrob Agents Chemother 51(8):2905-10 (2007) PMID 17526757
  25. SM16, an orally active TGF-beta type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model. Arterioscler Thromb Vasc Biol 28(4):665-71 (2008) PMID 18202322
  26. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts. Arthritis Rheum 50(12):4008-21 (2004) PMID 15593186
  27. Inhibition of the TGF-beta receptor I kinase promotes hematopoiesis in MDS. Blood 112(8):3434-43 (2008) PMID 18474728
  28. Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br J Pharmacol 145(2):166-77 (2005) PMID 15723089
  29. A novel small-molecule inhibitor of transforming growth factor beta type I receptor kinase (SM16) inhibits murine mesothelioma tumor growth in vivo and prevents tumor recurrence after surgical resection. Cancer Res 67(5):2351-9 (2007) PMID 17332368
  30. SB-431542 and Gleevec inhibit transforming growth factor-beta-induced proliferation of human osteosarcoma cells. Cancer Res 63(22):7791-8 (2003) PMID 14633705
  31. Tumor-specific efficacy of transforming growth factor-beta RI inhibition in Eker rats. Clin Cancer Res 13(10):3087-99 (2007) PMID 17505012
  32. TGFbeta induces SIK to negatively regulate type I receptor kinase signaling. J Cell Biol 182(4):655-62 (2008) PMID 18725536
  33. Intracellular TGF-beta receptor blockade abrogates Smad-dependent fibroblast activation in vitro and in vivo. J Invest Dermatol 126(8):1733-44 (2006) PMID 16741519
  34. Inhibition of gene markers of fibrosis with a novel inhibitor of transforming growth factor-beta type I receptor kinase in puromycin-induced nephritis. J Pharmacol Exp Ther 313(3):943-51 (2005) PMID 15769863
  35. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol Pharmacol 65(3):744-52 (2004) PMID 14978253
  36. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol 62(1):65-74 (2002) PMID 12065756
  37. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol Pharmacol 62(1):58-64 (2002) PMID 12065755
  38. Inhibitory effect of blocking TGF-beta/Smad signal on injury-induced fibrosis of corneal endothelium. Mol Vis 14():2272-81 (2008) PMID 19081766
  39. Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis. EMBO Rep 7(8):831-7 (2006) PMID 16845371
  40. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5. Mol Endocrinol 18(3):653-65 (2004) PMID 14684852

2 Andere Lexika

Diesen Artikel melden!
Verletzt dieser Artikel deine Urheber- oder Persönlichkeitsrechte?
Hast du einen Löschwunsch oder ein anderes Anliegen? Dann nutze bitte unser Kontaktformular

PlusPedia Impressum
Diese Seite mit Freunden teilen:
Mr Wong Digg Delicious Yiggit wikio Twitter
Facebook




Bitte Beachte:
Sämtliche Aussagen auf dieser Seite sind ohne Gewähr.
Für die Richtigkeit der Aussagen übernimmt die Betreiberin keine Verantwortung.
Nach Kenntnissnahme von Fehlern und Rechtsverstößens ist die Betreiberin selbstverständlich bereit,
diese zu beheben.

Verantwortlich für jede einzelne Aussage ist der jeweilige Erstautor dieser Aussage.
Mit dem Ergänzen und Weiterschreiben eines Artikels durch einen anderen Autor
werden die vorhergehenden Aussagen und Inhalte nicht zu eigenen.
Die Weiternutzung und Glaubhaftigkeit der Inhalte ist selbst gegenzurecherchieren.


Typo3 Besucherzähler - Seitwert blog counter
java hosting vpn norway